CI 102.21 Cigna Corp $CI Hit a 52 week high of 102.97

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
CI 102.21 Cigna Corp $CI Hit a 52 week high of 102.97 Closing the day 09:45 at 102.21 -0.50 -0.49% With a day low of 101.91 and a total volume of 90,810.

CI Recent Posts: http://investorshangout.com/Cigna-Corp-CI-50520/

CI Cigna Corp Recent Headline News

Early Glance: Managed Care companies
AP - 27 mins ago
NEW YORK (AP) — Shares of some top managed care companies are down at 10 a.m.:
CI: 102.24 (-0.47), UNH: 95.50 (-0.40), AET: 84.24 (-0.32), HUM: 137.08 (-1.33)

Stock Picking Grades For All Cap Value Style Fund Managers
David Trainer - Seeking Alpha - 1 hr 44 mins ago
This report shows how well All Cap Value mutual fund managers pick stocks. We juxtapose our Portfolio Management Rating on funds, which grades managers based on the quality of the stocks they choose, with the number of good stocks available in the...
CI: 102.24 (-0.47), XPO: 36.94 (-0.16)

Final Glance: Managed Care companies
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — Shares of some top managed care companies were mixed at the close of trading:
CI: 102.24 (-0.47), UNH: 95.50 (-0.40), AET: 84.24 (-0.32), HUM: 137.08 (-1.33)

Midday Glance: Managed Care companies
AP - Thu Nov 13, 12:28PM CST
NEW YORK (AP) — Shares of some top managed care companies are up at 1 p.m.:
CI: 102.24 (-0.47), UNH: 95.50 (-0.40), AET: 84.24 (-0.32), HUM: 137.08 (-1.33)

Dialing Back Chronic Disease with Mobile Phones in India, Thanks to Cigna Foundation; $260,000 World of Difference grant awarded to Arogya World
Business Wire - Wed Nov 12, 7:00AM CST
--Assisting in development: Emory University, Vignet Corporation
CI: 102.24 (-0.47)

Technical Data on Managed Health Care Equities - Aetna, WellPoint, Humana, UnitedHealth, and Cigna
PR Newswire - Tue Nov 11, 7:30AM CST
Investor-Edge has initiated coverage on the following equities: Aetna Inc. (NYSE: AET), WellPoint Inc. (NYSE: WLP), Humana Inc. (NYSE: HUM), UnitedHealth Group Inc. (NYSE: UNH), and Cigna Corporation (NYSE: CI). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Monday, November 10, 2014, the NASDAQ Composite ended at 4,651.62, up 0.41%, the Dow Jones Industrial Average advanced 0.23%, to finish the day at 17,613.74, and the S&P 500 closed at 2,038.26, up 0.31%. The gains were broad based as eight out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 783.00, up 1.00%, with the index also advancing 11.86% in the previous three months. Register for your complimentary reports on these five stocks at:
CI: 102.24 (-0.47), UNH: 95.50 (-0.40), AET: 84.24 (-0.32), WLP: 125.91 (-0.72), HUM: 137.08 (-1.33)

Alzheimer's Association(R) to Develop E-Learning Program with Cigna Foundation Grant; Online Social Support for People Living in Early Stage
Business Wire - Mon Nov 10, 10:09AM CST
--Cigna-HealthSpring launches month-long Facebook awareness campaign
CI: 102.24 (-0.47)

Earnings Flashback: Since Reporting Quarterly Results 1 Week Ago CIGNA Is Up 1.9% (CI)
Comtex SmarTrend(R) - Mon Nov 10, 7:58AM CST
When CIGNA (NYSE:CI) reported earnings 11 days ago on October 30th, 2014, analysts, on average, expected the company to report earnings of $1.82 on sales of $8.6 billion. CIGNA actually reported earnings of $1.95 per share on sales of $8.8 billion, beating EPS estimates by $0.12 and beating revenue estimates by $110.4 million. Shares of CIGNA have climbed from $97.10 to $98.99, representing a gain of 1.9% since the company reported earnings 11 days ago.
CI: 102.24 (-0.47)

3 Things That Can Keep the Wind in Catamaran Corp.'s Sails
Keith Speights, The Motley Fool - Motley Fool - Sat Nov 08, 8:00AM CST
It's been a relatively rough year for Catamaran Corporation so far. Just a couple of weeks ago, the pharmacy benefits manager's stock was down more than 10% and even farther away from the highs seen in 2013. After a strong third-quarter earnings...
CI: 102.24 (-0.47), ESRX: 77.94 (+0.04), CTRX: 48.36 (+0.13), CVS: 89.71 (-0.42)

Shave and a Haircut - and Colorectal Cancer Screenings: Maryland Center for Health Equity and the Cigna Foundation Train Barbers, Stylists as Community Health Advocates
Business Wire - Fri Nov 07, 8:00AM CST
--Barbers and hair stylists - trusted voices in the community - to be trained as health advocates to encourage customers to have screenings
CI: 102.24 (-0.47)

Cigna, BJC HealthCare and Washington University Physicians Collaborate to Launch Cigna Individual and Family Plans in St. Louis
Business Wire - Fri Nov 07, 7:30AM CST
--Affordable, quality care for patients provided by BJC HealthCare and Washington University Physicians
CI: 102.24 (-0.47)

Connecticut State Medical Society-IPA, Inc. and Cigna Launch Statewide Collaborative Care Program that Reaches Small and Mid-Size Medical Practices
Business Wire - Thu Nov 06, 10:00AM CST
--Primary care doctors are rewarded for improving patient health and lowering medical costs
CI: 102.24 (-0.47)

Cigna Corp. (CI) Stock Research Links

CI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FLUX 3 Max Launches with Unmatched Speed and Quality

Updated Category News Views 19

A Lightning Fast Leap in Video Generation It's all eyes on FLUX 3 Max today. You can almost hear the gasps of 'wow' in the generative media crowd. Why? Because this new weapon in the video gen arsenal, dreamed up by fal and Black Forest Labs, is slicing through the old speed limits like a blistering comet. Now, don't get me wrong. Seeds don't grow overnight, and neither...

Continue Reading
CMS Proposal Sparks Controversy in Lab Certification

Updated Category News Views 8

A New Contender in the Battle Over Lab Standards Here's what’s heating up in the realm of clinical laboratories: A proposed shift by the Centers for Medicare & Medicaid Services (CMS) that reeks of cutting corners, if you ask the folks at the Association for Diagnostics & Laboratory Medicine (ADLM). They’re banging the drums against CMS's idea to nix the board...

Continue Reading
INSPIRE 2026: Luxury Hotel Trends and Investments

Updated Category News Views 7

Luxury Hotels: Where's the Money Headed? All eyes on Orlando this December 15–16, where the International Luxury Hotel Association (ILHA) is calling the shots. INSPIRE 2026 is the marquee event of the year for luxury hospitality, and it ain't just about starry chandeliers and velvet drapes. We're talking real capital shifts, margins pinching tighter, and a future...

Continue Reading
Endava Faces Securities Fraud Lawsuit: Investor Implications

Updated Category News Views 8

Endava in Hot Water Over Alleged Misleading Statements Alright, folks, gather around—there's a storm brewing over at Endava with shareholders mightier than the Greek gods, furrowing their brows with intent. You see, Schall, Brown & Schwartz LLP, a firm that practically eats legal challenges for breakfast, is beating the drums of a securities fraud lawsuit. Yep, I'm...

Continue Reading
PG&E Delivers $26M Climate Credit to Small Biz

Updated Category News Views 2

California's Big Move for Small Businesses In a world where every dollar counts, small businesses across Northern and Central California are getting a helping hand. Pacific Gas and Electric Company (PG&E) is stepping up with a tidy little climate credit thanks to the state's Cap-and-Invest Program. Eligible businesses are automatically set to receive a $36.18 credit off...

Continue Reading
Brown Plus Ranks #8 Best Workplace for Women 2026

Updated Category News Views 5

Cracking the Top Ten: A Noteworthy Feat When it comes to hustling and bustling in the corporate world, Brown Plus managed to snag the spotlight by landing the #8 spot in the 'Best Place to Work for Women 2026.' It's a title they didn't just stumble upon. This recognition in the medium category by the Best Companies Group underscores the fact that Brown Plus is running its...

Continue Reading
Kenneth Smith Takes Helm for Trends Int’l Expansion

Updated Category News Views 12

Tired of the Same Old Leadership Shuffle? Here Comes Kenneth Smith Look, I’ve seen my share of execs come and go, usually dragging the same old briefcase of stale ideas. But Kenneth Smith stepping up as CEO of Trends International? Now that’s got some real teeth to it. Come May 2026, he’s the guy at the helm, and he's got one hell of a to-do list. Smith's Roadmap: A...

Continue Reading
JELD-WEN CFO Transition: Navigating Finances Amid Changes

Updated Category News Views 6

Leadership Shake-up at JELD-WEN Alright, folks, the boardroom saga over at JELD-WEN just took another spin. Samantha Stoddard, the brain behind the numbers as Chief Financial Officer, is packing her bags come mid-November. Yeah, she's off to chase new horizons outside the realm of building products, leaving a spot hotter than a New York Stock Exchange ring bell up for...

Continue Reading
Hyliion Legal Woes Shake Investor Confidence

Updated Category News Views 2

Legal Storm Brews Over Hyliion Investments If you think riding the stock market is like sailing a calm sea, wake up. Hyliion Holdings Corp. (NYSE:HYLN) finds itself steaming headlong into rough waters. A securities class action lawsuit, Olmeta v. Hyliion Holdings Corp., accuses the company of embellishing its ambitions. The lawsuit cites potential wrongdoing in a...

Continue Reading
Flotek Faces Class Action as PREPA Contract Dissolves

Updated Category News Views 0

Flotek's 10-Year Project Shattered by Canceled Agreement Here's a brew you won't find down at any greasy spoon: Flotek Industries (NYSE: FTK) finds itself tangled in a legal web after their highly touted project in Puerto Rico went belly-up. That's one heck of a slice off their revenue pie, and investors best have their radar turned on. The lawsuit's all about what's...

Continue Reading

Top 5 Most Recently Viewed Articles

Nektar Therapeutics Announces Key Stock Option Grants for New Employees

Updated Category News Views 124

Nektar Therapeutics' New Stock Option Grants for Employees Nektar Therapeutics (NASDAQ: NKTR) has made an important announcement regarding the granting of stock options designed to attract new talent. Recently, their Board of Directors revealed that, under its 2025 Inducement Plan, they granted a considerable number of stock options aimed at supporting the interests of a...

Continue Reading
B2Gold Celebrates Successful Commercial Launch of Goose Mine

Updated Category News Views 157

Exciting Developments at the Goose Mine VANCOUVER, British Columbia -- B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) is thrilled to share that the Goose Mine has officially achieved commercial production, marking a significant milestone for the company. Production Milestone and Operations Update The declaration of commercial production at the Goose Mine came after...

Continue Reading
Tesla's Optimus Robot Advances in Autonomous Capabilities

Updated Category News Views 410

Tesla's Optimus Robot Takes Strides in Autonomy Tesla Inc. recently unveiled a captivating video showcasing its Optimus humanoid robot deftly navigating a factory environment. This demonstration emphasizes significant advancements in the robot's technology, particularly its autonomous navigation and charging capabilities. Robust Navigation Skills The latest video...

Continue Reading
monday.com Set to Reveal Financial Performance for 2024

Updated Category News Views 113

monday.com Financial Results Announcement monday.com (NASDAQ: MNDY), the innovative platform that enhances work management, has highlighted its commitment to transparency and investor engagement. The company has announced an upcoming report on its financial results for the fourth quarter and fiscal year 2024. This key announcement is scheduled for the morning of February...

Continue Reading
BioCryst Pharmaceuticals Holds Strong Position for Investors

Updated Category News Views 34

BioCryst Pharmaceuticals Maintains Strong Market Position Recently, BofA Securities reiterated its Buy rating for BioCryst Pharmaceuticals (NASDAQ:BCRX), maintaining a price target of $11.00. This assessment came on the heels of an encouraging third-quarter earnings report, where Orladeyo sales hit $116.3 million, surpassing expectations set by both BofA and market...

Continue Reading